Bárbara Ferreira

Dr. Bárbara Ferreira

Department of Chemistry & CICECO, University of Aveiro
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2021 in Materials
Verified
Journal Article
Open access
PDF file
Diogo MarinheiroDiogo Marinheiro
Diogo Marinheiro
Bárbara FerreiraBárbara Ferreira
Bárbara Ferreira
POPárástu Oskoei
Párástu Oskoei
HOHelena Oliveira
Helena Oliveira
Ana Luísa Daniel-da-SilvaAna Luísa Daniel-da-Silva
Ana Luísa Daniel-da-Silva
Chemotherapy has limited success in the treatment of malignant melanoma due to fast development of drug resistance and the low bioavailability of chemotherapeutic drugs. Resveratrol (RES) is a natural polyphenol with recognized preventive and therapeutic anti-cancer properties. However, poor RES solubility hampers its bioactivity, thus creating a demand for suitable drug delivery systems to improve it. This work aimed to assess the potential of RES-loaded mesoporous silica nanoparticles (MSNs) for human melanoma treatment. RES was efficiently loaded (efficiency > 93%) onto spheroidal (size~60 nm) MSNs. The encapsulation promoted the amorphization of RES and enhanced the release in vitro compared to non-encapsulated RES. The RES release was pH-dependent and markedly faster at pH 5.2 (acid environment in some tumorous tissues) than at pH 7.4 in both encapsulated and bulk forms. The RES release from loaded MSNs was gradual with time, without a burst effect, and well-described by the Weibull model. In vitro cytotoxicity studies on human A375 and MNT-1 melanoma cellular cultures showed a decrease in the cell viability with increasing concentration of RES-loaded MSNs, indicating the potent action of the released RES in both cell lines. The amelanotic cell line A375 was more sensitive to RES concentration than the melanotic MNT-1 cells.

Verified
Journal Article
Open access
PDF file
Ariana SantosAriana Santos
Ariana Santos
Luís Gomes MonteiroLuís Gomes Monteiro
Luís Gomes Monteiro
AGAdriana Gomes
Adriana Gomes
Fátima MartelFátima Martel
Fátima Martel
TSTeresa Santos
Teresa Santos
Bárbara FerreiraBárbara Ferreira
Bárbara Ferreira
After the serendipitous discovery of cisplatin, a platinum-based drug with chemotherapeutic effects, an incredible amount of research in the area of coordination chemistry has been produced. Other transition metal compounds were studied, and several new relevant metallodrugs have been synthetized in the past few years. This review is focused on coordination compounds with first-row transition metals, namely, copper, cobalt, nickel or manganese, or with zinc, which have potential or effective pharmacological properties. It is known that metal complexes, once bound to organic drugs, can enhance the drugs’ biological activities, such as anticancer, antimicrobial or anti-inflammatory ones. NSAIDs are a class of compounds with anti-inflammatory properties used to treat pain or fever. NSAIDs’ properties can be strongly improved when included in complexes using their compositional N and O donor atoms, which facilitate their coordination to metal ions. This review focuses on the research on this topic and on the promising or effective results that complexes of first-row transition metals and NSAIDs can exhibit.

1 August 2016 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
Bárbara FerreiraBárbara Ferreira
Bárbara Ferreira
PBPaula Brandão
Paula Brandão
MMM. Meireles
M. Meireles
Fátima MartelFátima Martel
Fátima Martel
ACAna Correia-Branco
Ana Correia-Branco
VFVítor Félix
Vítor Félix

1 January 2009 in Acta Biomaterialia
Verified
Journal Article
Closed access
PLP Lopes
P Lopes
MCM Corbellini
M Corbellini
Bárbara FerreiraBárbara Ferreira
Bárbara Ferreira
NAN Almeida
N Almeida
MFM Fredel
M Fredel
RCR Correia
R Correia

15 June 2023 in Molecules
Verified
Journal Article
Open access
PDF file
CCCatarina Cunha
Catarina Cunha
Diogo MarinheiroDiogo Marinheiro
Diogo Marinheiro
Bárbara FerreiraBárbara Ferreira
Bárbara Ferreira
HOHelena Oliveira
Helena Oliveira
Ana Luísa Daniel-da-SilvaAna Luísa Daniel-da-Silva
Ana Luísa Daniel-da-Silva
Melanoma incidence, a type of skin cancer, has been increasing worldwide. There is a strong need to develop new therapeutic strategies to improve melanoma treatment. Morin is a bioflavonoid with the potential for use in the treatment of cancer, including melanoma. However, therapeutic applications of morin are restrained owing to its low aqueous solubility and limited bioavailability. This work investigates morin hydrate (MH) encapsulation in mesoporous silica nanoparticles (MSNs) to enhance morin bioavailability and consequently increase the antitumor effects in melanoma cells. Spheroidal MSNs with a mean size of 56.3 ± 6.5 nm and a specific surface area of 816 m2/g were synthesized. MH was successfully loaded (MH-MSN) using the evaporation method, with a loading capacity of 28.3% and loading efficiency of 99.1%. In vitro release studies showed that morin release from MH-MSNs was enhanced at pH 5.2, indicating increased flavonoid solubility. The in vitro cytotoxicity of MH and MH-MSNs on human A375, MNT-1 and SK-MEL-28 melanoma cell lines was investigated. Exposure to MSNs did not affect the cell viability of any of the cell lines tested, suggesting that the nanoparticles are biocompatible. The effect of MH and MH-MSNs on reducing cell viability was time- and concentration-dependent in all melanoma cell lines. The A375 and SK-MEL-28 cell lines were slightly more sensitive than MNT-1 cells in both the MH and MH-MSN treatments. Our findings suggest that MH-MSNs are a promising delivery system for the treatment of melanoma.

1 December 2020 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
Bárbara FerreiraBárbara Ferreira
Bárbara Ferreira
Fátima MartelFátima Martel
Fátima Martel
CSC. Silva
C. Silva
TST.M. Santos
T.M. Santos
Ana Luísa Daniel-da-SilvaAna Luísa Daniel-da-Silva
Ana Luísa Daniel-da-Silva